20 (AIDX) Interest & Investment Income (2025 - 2026)
20's (AIDX) quarterly Interest & Investment Income came in at $6653.0 in Q1 2026, down 21.34% YoY from $8458.0 in Q1 2025, and down 21.34% on a QoQ basis from $8458.0 in Q1 2025.
20 (AIDX) Interest & Investment Income (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Interest & Investment Income data on file, last reported at $6653.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | - |
| 10 | 20 | 5.60 Mn | 1.05 Mn | 304,727.00 | 14,476.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,653.00 |
| Mar 31, 2025 | 8,458.00 |